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Abstract
Background: The prevalence of patients with end stage renal disease (ESRD) who need dialysis
and/or transplantation has more than doubled in Thailand during the past two decades. It has been
suggested that therapeutic strategies to reduce the risk of ESRD and other complications in CKD
are now available, thus the early recognition and the institution of proven therapeutic strategies
are important and beneficial. We, therefore, aimed to determine the prevalence of CKD in Thai
adults from the National Health Examination Survey of 2004.
Methods: Data from a nationally representative sample of 3,117 individuals aged 15 years and
older was collected using questionnaires, physical examination and blood samples. Serum creatinine
was measured by Jaffé method. GFR was estimated using the Chinese modified Modification of Diet
in Renal Disease Study equation. Chronic kidney Disease (CKD) stages were classified based on
Kidney Disease Outcome Quality Initiative (K/DOQI).
Results: The prevalence of CKD in Thai adults weighted to the 2004 Thai population by stage was
8.1% for stage 3, 0.2% and 0.15% for stage 4 and 5 respectively. Compared to non-CKD, individuals
with CKD were older, had a higher level of cholesterol, and higher blood pressure. Those with
cardiovascular risk factors were more likely to have CKD (stage 3-5) than those without, including
hypertension (OR 1.6, 95%CI 1.1, 3.4), diabetes (OR 1.87, 95%CI 1.0, 3.4). CKD was more
common in northeast (OR 2.1, 95%CI 1.3, 3.3) compared to central region. Urinalysis was not
performed, therefore, we could not have data on CKD stage 1 and 2. We have no specific GFR
formula for Thai population.
Conclusion:  The identification of CKD patients should be evaluated and monitored for
appropriate intervention for progression to kidney disease from this screening.
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Background
The prevalence of patients with end stage renal disease
(ESRD) who need dialysis and/or transplantation has
more than doubled in Thailand during the past two dec-
ades [1,2]. In addition to being at risk of ESRD, people
with chronic kidney disease (CKD) have an increased risk
of cardiovascular death [3,4]. Besides, chronic kidney dis-
ease is associated with an increased risk of a multitude of
adverse health outcomes, including end stage kidney dis-
ease (ESRD) as well as a substantial reduction in life
expectancy [3,5]. ESRD has a profound effect on morbid-
ity, mortality and quality of life and imposes a substantial
burden on health care expenditure [6]. Therapeutic strate-
gies to reduce the risk of ESRD and other complications in
CKD are now available [7]. So early recognition and the
institution of proven therapeutic strategies are important
and beneficial.
Large population representative surveys in the United
States and Australia have reported the prevalence of CKD
in these countries [8,9]. However, much less information
is available on prevalence rates in developing regions
[10]. Given their the limited ability to afford to provide
dialysis and the rapidly increasing prevalence of diabetes
and hypertension that may predispose to the develop-
ment of CKD, preventive strategies are the only cost effec-
tive measure in these countries [11].
The purpose of this study is to estimate the prevalence of
CKD among adults in Thailand.
Methods
The third National Health Examination Survey (NHES III)
is a national representative survey of Thai population and
was conducted by the Health Research Institute. The study
was approved by the Ethical Review Committee for
Research in Human Subjects, Ministry of Public Health
and informed consent was obtained from all participants.
Data were collected between January and May of the year
2004.
Sampling design
Multistage stratified cluster sampling technique was used
to recruit study participants. The sampling technique was
described elsewhere [12]. Briefly, the country was firstly
divided into 13 areas (12 public health areas and Bang-
kok) using data from the national registration. Next, for
each area, except Bangkok, three provinces were randomly
selected using proportional to size (PPS) probability.
Then each selected province was divided into rural and
urban areas. The areas were subsequently sampled for 9
villages or electoral units using PPS. The last sampling step
was to randomly select 15 people for 4 distinct age and sex
groups, males aged 15-59 and males aged 60 years or
above, and females aged 15-59 and females aged 60 years
or above, using simple random sampling. Bangkok was
divided into 6 administrative areas and 9 electoral units
were selected for each area using PPS. The final sample
size for NHES III was 39,290 compared to 42,120 planned
(93.3%). Data were collected through interviews, popula-
tion characteristics included demographic, medical his-
tory and treatment. Appointments were made with
individuals in advance for blood sample collection.
Venous blood samples were obtained by trained nurses
under close supervision of physicians, using aseptic tech-
nique vacuum syringes and disposable needles. Physical
examinations were performed and laboratory blood tests
were obtained for measurement of fasting plasma glucose,
and total cholesterol but not creatinine. However, serum
samples were obtained and stored at -80 degree Celsius.
Measurement of serum creatinine
The serum samples collected at time in the NHES III were
stored at -80 degree Celsius. In the present study, a total of
3,120 serum samples were randomly selected propor-
tional to the sample size of each age group, sex, urban/
rural and public health area strata. In 2007, the selected
frozen serum samples were thawed and analyzed for
serum creatinine using a modified kinetic Jaffé method
using automatic analyzer MERCK model MEGA, Germany
under the External Quality Assurance Services (EQAS) of
Biorad Laboratories, USA (Monthly Clinical Chemistry
Quality Assessment Programme).
Definitions
In this study, chronic kidney disease (CKD) means indi-
viduals who self-reported as receiving dialysis or who had
glomerular filtration rates < 60 milliliters/minute (mL/
min) calculated using the Modification of Diet in Renal
Disease (MDRD) formula with adjustment for Asian eth-
nicity (GFR = 186 × serum creatinine-1.154 × age (in years)-
0.203 × 1.233 (for Asian) × 0.742 (if female)). Hyperten-
sion means having systolic blood pressure (SBP) ≥140
mmHg or diastolic blood pressure (DBP) ≥90 mmHg or
having used blood pressure lowering medication over the
past 2 weeks.
The CKD staging was categorized based on the classifica-
tion system established by the National Kidney Founda-
tion Kidney Disease Outcomes Quality Initiatives. In the
absence of urine albumin data, we only report stages 3 to
5. Stages 3 to 5 are defined as follows: stage 3, a GFR of 30
to 59 mL/min/1.73 m2; stage 4, a GFR of 15-29 mL/min/
1.73 m2; stage 5, a GFR of less than 15 mL/min/1.73 m2.
An average of 2 measurements of blood pressure with the
lowest variation of the differences between SBP and DBP
was used. Diabetes mellitus means having fasting blood
sugar ≥126 mg/dL or currently using medication or insu-
lin for lowering blood sugar. HypercholesterolemiaBMC Nephrology 2009, 10:35 http://www.biomedcentral.com/1471-2369/10/35
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means having total cholesterol ≥240 mg/dL (6.7 mmol/L)
or currently using cholesterol lowering medications. Body
mass index is the ratio between body mass (in kilogram)
and the product of height (in metre). Smoking refers to
those who had smoked 100 cigarettes or more and were
using tobacco at the time of interview.
Statistical analysis
Analyses with appropriate sample weights taking into
account of the complex survey design were used to obtain
unbiased estimates for prevalence of CKD and average
measures of kidney function in Thai population. Esti-
mates by demographic characteristic and risk factors were
age-standardized to the 2004 Thai population.
Adjusted Wald tests were used to test for statistically sig-
nificant difference between groups at 95% confidence
level (P < 0.05). Logistic regression was used to measure
the association between major risk factors and CRF (GFR
< 60 mL/min). The independent variables were age,
region, sex, BMI, total cholesterol, hypertension, diabetes
mellitus, and smoking.
Stata 9.2 software program was used for all data analysis
(Stata corporation, Texas).
Results
Table 1 shows baseline characteristics of 3,117 partici-
pants, 1,557 male and 1,560 female by sex, age, FPG, total
cholesterol, BMI, blood pressure, hypertension creatinine,
and estimated GFR.
Mean systolic blood pressure was 115.3 mmHg (male
118.5 mmHg and female 112.2 mmHg), diastolic blood
pressure, 74.7 mmHg (male 76.8 mmHg and female 72.8
mmHg). Prevalence of hypertension was 22.5% with
higher prevalence in male than in female (25.9% vs
19.1%), FPG 92.1 mg/dL (male 93.9 mg/dL and female
90.5 mg/dL), with prevalence of diabetes 7.0%. Average
BMI was higher in female than male: BMI 23.2 kg/m2
(male 22.6 kg/m2 and female 23.8 kg/m2). Mean creati-
nine level was greater in men than in women (1.3 mg/dL
vs 1.1 mg/dL). The estimated mean GFR according to the
modified MDRD was 78.9 mL/min (men 82.7 mL/min
and women 75.2 mL/min).
Prevalence of Chronic Kidney Disease (Table 2)
Age-standardized CKD prevalence stage 3 to 5 estimated
for Thai adults aged ≥15 years was 8.9%. The prevalence
by disease stages were as follows: stage 3, 8.1%; stage 4,
0.2%, and stage 5, 0.2%. By age group, CKD prevalence
increased with advancing age as follows: aged < 29 years
Table 1: Characteristic of sample in a subsample of Thai adults aged 15 years in NHES III, 2004
Factors Men (%)
n = 1557
Women (%)
n = 1560
Total (%)
n = 3117
Age (mean, SE) 33.8 ± 0.5 33.3 ± 0.5 33.6 ± 0.4
Sex (population) 49.1% 50.9% 100%
Age group (yr)
15-29 390 (25.0%) 390 (25.0%) 780 (25.0%)
30-44 390 (25.0%) 390 (25.0%) 780 (25.0%)
45-59 388 (24.9%) 390 (25.0%) 778 (25.0%)
≥ 60 389 (25.0%) 390 (25.0%) 779 (25.0%)
Urban/rural
Urban 839 (53.9%) 840 (53.9%) 1679 (53.9%)
Rural 718 (46.1%) 720 (46.1%) 1438 (46.1%)
Region
Central 479 (30.8%) 480 (30.8%) 959 (30.8%)
Northeast 360 (23.1%) 360 (23.1%) 720 (23.1%)
North 360 (23.1%) 360 (23.1%) 720 (23.1%)
South 238 (15.3%) 240 (15.4%) 478 (15.3%)
Bangkok 120 (7.7%) 120 (7.7%) 240 (7.7%)
Hypertension* (%) 26.0 19.1 22.5
Diabetes* (%) 6.6 7.5 7.0
TC* (mean ± SE) 188.9 ± 2.0 196.3 ± 2.0 192.8 ± 1.8
High cholesterol* (TC ≥ 240 mg/dL) 12.8 16.5 14.7
BMI* (mean ± SE), kg/m2 22.6 ± 0.2 23.8 ± 0.2 23.2 ± 0.1
Smoking* (%) 46.0 2.6 24.3
Creatinine* (mean ± SE), mg/dL 1.3 ± 0.01 1.1 ± 0.01 1.2 ± 0.01
GFR* (mean ± SE), mL/min 82.7 ± 0.4 75.2 ± 0.3 78.9 ± 0.3
(*age standardized)BMC Nephrology 2009, 10:35 http://www.biomedcentral.com/1471-2369/10/35
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(0.4%), 30-44 years (2.3%), 45-59 years (13.1%), and
aged ≥60 years (39.8%).
CKD prevalence was slightly higher among persons in
rural areas than those in urban areas (9.2% vs 8.0%, P <
0.05). CKD prevalence was greater among persons in
Northeast (10.8%) than those in other regions (north
8.9%, south 8.1%, Bangkok 6.2%, all P < 0.05).
Characteristics of those with CKD (Table 3)
Those with CKD (GFR < 60 mL/min) had a mean GFR of
47.2 mL/min while those with GFR ≥60 mL/min had a
mean of 80.8 mL/min (P < 0.001).
The mean systolic blood pressure was higher in CKD than
those without CKD (129.7 mmHg vs 118.0 mmHg, P <
0.001).
The proportion of hypertension was higher in those with
CKD than those without CKD (49.9% vs 21.8%, P < 0.05).
Those with CKD also had higher prevalence of diabetes
(14.6% vs 6.5%, P = 0.06), a higher level of cholesterol
(223.5 mg/dL vs 192.4 mg/dL, P < 0.05) and greater BMI
(24.4 kg/m2 vs 23.1 kg/m2, P = 0.07) compared to those
without CKD.
Factors associated with CKD
Table 4 shows factors that were associated with CKD in
logistic regression model. After controlling for sex, hyper-
tension, diabetes, smoking and BMI, age was strongly
associated with CKD, the odds ratio of CKD was 3.0 times
for an increase of 10 years of age. CKD was also strongly
associated with diabetes (OR, 1.9; 95%CI, 1.0, 3.5),
hypertension (OR, 1.6; 95%CI, 1.1, 2.5), BMI (OR, 1.2 for
an increase in 1SD).
Table 2: Age-standardized prevalence (95% confidence interval) of CKD by sex, urban/rural and region using MDRD (× 1.233) formula
Stage3 Stage4 Stage5 Total
Total 8.1 (7.3, 9.1) 0.2 (0.1, 0.5) 0.2 (0.1, 0.4) 8.9 (8.0, 9.9)
Sex
Men 4.8 (3.8, 6.0) 0 (0, 0.4) 0.1 (0, 0.6) 5.5 (4.3, 6.8)
Women 11.4 (10.1, 12.9) 0.4 (0.2, 0.8) 0.2 (0.0, 0.6) 12.3 (10.8, 13.8)
Age group (yr)
15-29 0.2 (0, 1.3) 0 0 0.4 (0.1, 1.2)
30-44 1.5 (0.7, 3.0) 0 0.2 (0, 1.1) 2.3 (1.3, 4.1)
45-59 12.4 (9.5, 16.0) 0.3 (0, 2.0) 0.2 (0, 1.7) 13.1 (10.1, 16.8)
≥ 60 37.7 (33.6, 42.0) 1.4 (0.5, 3.5) 0.5 (0.1, 2.2) 39.8 (35.6, 44.1)
Area of residence
Urban 7.7 (6.4, 9.1) 0.1 (0, 0.6) 0.1 (0, 0.9) 8.0 (6.7, 9.6)
Rural 8.3 (7.3, 9.5) 0.2 (0.1, 0.6) 0.2 (0.1, 0.5) 9.2 (8.1, 10.5)
Region
Central 7.2 (5.9, 8.8) 0.1 (0, 0.7) 0.1 (0, 0.9) 7.4 (6.2, 9.0)
Northeast 10.1 (8.5, 11.9) 0.1 (0, 0.4) 0.2 (0, 1.0) 10.8 (8.9, 13.0)
North 7.8 (6.0, 10.0) 0.6 (0.2, 1.7) 0.2 (0, 1.3) 8.9 (6.8, 11.3)
South 6.4 (4.7, 8.7) 0.2 (0, 0.9) 0 8.1 (6.5, 10.0)
Bangkok 6.2 (4.5, 8.4) 0 0 6.2 (4.5, 8.4)
Table 3: Characteristics of CKD based on the MDRD (× 1.233) formula
Characteristics No CKD
(n = 2971)
CKD (stage 3-5)
(n = 146)
P value
Age, yr (SE) 32.3 (0.4) 56.8 (1.2) < 0.001
Men, % (SE) 50.1 (1.5) 30.4 (3.4) < 0.001
*GFR, mL/min/1.73 m2 (SE) 80.8 (0.3) 47.2 (2.5) < 0.001
*Systolic blood pressure, mmHg (SE) 118.0 (0.6) 129.7 (2.0) < 0.001
*Hypertension, % (SE) 21.8 (1.3) 49.9 (9.8) < 0.05
*BMI (SE) 23.1 (0.1) 24.4 (0.7) 0.07
*Cholesterol, mg/dL (SE) 192.4 (1.7) 223.5 (13.1) < 0.05
*Smoking, % (SE) 25.4 (1.0) 26.0 (8.3) 0.94
*Diabetes, % (SE) 6.5 (1.0) 14.6 (4.2) 0.06
*Age standardizedBMC Nephrology 2009, 10:35 http://www.biomedcentral.com/1471-2369/10/35
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Those who reside in northeast were also had a higher risk
of CKD compared to those from the central region (OR,
2.1; 95%CI, 1.3, 3.3).
Discussion
In this study, although we could report only CKD from
stage 3 to 5 of 8.9%, the information found is still a useful
baseline for further surveillance of situation of CKD in
Thailand Early detection is the most important factor
needed to tackle CKD, as management could be applied
to individual with impaired kidney function to reduce the
GFR declination and improve cardioprotection [13]. In
order to measure the renal function in this study, we use
the MDRD modified glomerular filtration rate estimating
equation for Chinese patients with CKD because this for-
mula was provided especially for the Asian population
[14]. MDRD has been reported to be more accurate in pro-
vide more acceptable estimation of GFR than GC equa-
tion in patients with GFR < 60 min/1.73 m2 [15]. The
authors chose this equation for improvement in bias, pre-
cision and accuracy when compared with the original
MDRD equation. Studies in Asian population, specifically
in Japanese and Chinese population have reported that
the original MDRD formula underestimate of GRF in their
population [16,17].
The percentage of the CKD prevalence in Thai adults was
previously reported in Royal Thai Air Force (RTAF) per-
sonnel who were routinely checked in January 2002 to
2003 [18]. This report included personnel 82 percent men
with mean age of 45.7 ± 8 years and was different from
our study which included population of both sex from 18
years to over 60 years. The prevalence of CKD in RTAF per-
sonnel from stage 3, 4, 5 was 2.9, 0.1, and 0.06% respec-
tively with an overall prevalence from stage 1 to 5 of 4.6%
using the MDRD equation and 9.1% using the Cockroft
and Gault formula. Another report of CKD prevalence [2]
in Thai employees of Electric Generation Authority of
Thailand, aged 35-55 years, showed prevalence of CKD
stage 3, 4, 5 of 6.4, 0.2, and 0.2% in 1997 to which the
author noted this prevalence of CKD was near the same
figure as in USA, Singapore, Taiwan and Japan [19-21].
Compared to other developing countries, the prevalence
was much lower than that reported in Africa such as
Republic of Congo, where the prevalence were 18% in
stage 3, 2% in stage 4 and 6% in stage 5 [22]. Recently,
there was also an interesting study showing a high preva-
lence of CKD in Thai population age 35 years and above
which was estimated to be about 20% using the Cockroft-
Gault formula and about 13% from the MDRD formula
[23]. The estimates are higher than that of the present
study due to the older age groups and the use of origin for-
mula without adjustment for Asian population. An addi-
tional analysis with the original formula in our data
provided a relatively high prevalence similar to results of
that study [23]; however, we believe that the estimated
prevalence derived from the modified formula is appro-
priate.
This study had some limitations. Firstly, we did not meas-
ure proteinuria so that we cannot estimate the early stage
of CKD. Secondly, the creatinine measurement was based
on Jaffe method which was available at time of the study,
current method of IDMS is not available. Thirdly, MDRD
equation was based on the original with coefficient cor-
rection for Chinese population which might be not
appropriate for Thai, as the formula specific for Thai pop-
ulation is not yet available. Lastly, as MDRD systemati-
cally underestimates GFR in healthy subject, CKD
prevalence tends to be overestimated in epidemiological
studies [24,25]. The incidence of ESRD among universal
health-care coverage in Thailand has been estimated to be
between 101 and 304 per million population (p.m.p.)
and although this range quite broad it is comparable to
Table 4: Adjusted odds ratios (OR) associated with CKD based on MDRD (× 1.233)
Adjusted OR 95% confidence interval
Age per 10 year 3.0 2.6, 3.4
Sex (female as reference) 0.3 0.2, 0.5
Diabetes 1.9 1.0, 3.5
Hypertension 1.6 1.1, 2.5
Smoking 1.2 0.6, 2.3
BMI per SD unit 1.2 1.0, 1.5
Total cholesterol per SD unit 1.1 0.8, 1.4
Rural (Urban as reference) 0.9 0.7, 1.3
Region
Central 1.0 1.0
Northeast 2.1 1.3, 3.3
North 1.7 1.0, 2.8
South 0.8 0.5, 1.3
Bangkok 0.8 0.4, 1.4
(SD of BMI = 4.41 kg/m2, SD of cholesterol = 46.76 mg/dL)BMC Nephrology 2009, 10:35 http://www.biomedcentral.com/1471-2369/10/35
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registry-based date from Australia (90-100 p.m.p), Europe
(85-160 p.m.p) and the United states (336 p.m.p). Factors
that are associated with the high prevalence of CKD in the
north and north eastern of Thailand should be urgently
sought out. Other risk factors of CKD in this study were
similar to other reports and included older age, diabetes
mellitus, hypertension, and elevated BMI. The prevalence
of CKD raises the possibility of a large burden of RRT over
the coming years and has profound public health implica-
tions. The findings of this study may offer a potential
opportunity for earlier therapeutic interventions to reduce
the rate of disease progression and incidence of ESRD.
Conclusion
CKD was common in Thai adults especially in the north
and northeast of Thailand. Effective prevention strategies
should be urgently sought and provided.
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